These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 35748819)

  • 1. Multifunctional magnetic nanoparticles for MRI-guided co-delivery of erlotinib and L-asparaginase to ovarian cancer.
    Mohaghegh S; Tarighatnia A; Omidi Y; Barar J; Aghanejad A; Adibkia K
    J Microencapsul; 2022 Jun; 39(4):394-408. PubMed ID: 35748819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methotrexate-conjugated chitosan-grafted pH- and thermo-responsive magnetic nanoparticles for targeted therapy of ovarian cancer.
    Fathi M; Barar J; Erfan-Niya H; Omidi Y
    Int J Biol Macromol; 2020 Jul; 154():1175-1184. PubMed ID: 31730949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erlotinib-Conjugated Iron Oxide Nanoparticles as a Smart Cancer-Targeted Theranostic Probe for MRI.
    Ali AA; Hsu FT; Hsieh CL; Shiau CY; Chiang CH; Wei ZH; Chen CY; Huang HS
    Sci Rep; 2016 Nov; 6():36650. PubMed ID: 27833124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-small cell lung cancer combination therapy: Hyaluronic acid modified, epidermal growth factor receptor targeted, pH sensitive lipid-polymer hybrid nanoparticles for the delivery of erlotinib plus bevacizumab.
    Pang J; Xing H; Sun Y; Feng S; Wang S
    Biomed Pharmacother; 2020 May; 125():109861. PubMed ID: 32070872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The enzyme-sensitive release of prodigiosin grafted β-cyclodextrin and chitosan magnetic nanoparticles as an anticancer drug delivery system: Synthesis, characterization and cytotoxicity studies.
    Rastegari B; Karbalaei-Heidari HR; Zeinali S; Sheardown H
    Colloids Surf B Biointerfaces; 2017 Oct; 158():589-601. PubMed ID: 28750341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. hTERT-molecular targeted therapy of ovarian cancer cells via folate-functionalized PLGA nanoparticles co-loaded with MNPs/siRNA/wortmannin.
    Ghareghomi S; Ahmadian S; Zarghami N; Hemmati S
    Life Sci; 2021 Jul; 277():119621. PubMed ID: 34004255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and construction of multifunctional hyperbranched polymers coated magnetite nanoparticles for both targeting magnetic resonance imaging and cancer therapy.
    Mashhadi Malekzadeh A; Ramazani A; Tabatabaei Rezaei SJ; Niknejad H
    J Colloid Interface Sci; 2017 Mar; 490():64-73. PubMed ID: 27870961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted delivery of doxorubicin by magnetic mesoporous silica nanoparticles armed with mucin-1 aptamer.
    Siminzar P; Omidi Y; Golchin A; Aghanejad A; Barar J
    J Drug Target; 2020 Jan; 28(1):92-101. PubMed ID: 31062625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functionalization of Magnetic Nanoparticles by Folate as Potential MRI Contrast Agent for Breast Cancer Diagnostics.
    Heydari Sheikh Hossein H; Jabbari I; Zarepour A; Zarrabi A; Ashrafizadeh M; Taherian A; Makvandi P
    Molecules; 2020 Sep; 25(18):. PubMed ID: 32899812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing the selective therapeutic efficacy of superparamagnetic erlotinib nanoparticles in lung cancer by using quantitative magnetic resonance imaging and a nuclear factor kappa-B reporter gene system.
    Hsu FT; Liu HS; Ali AAA; Tsai PH; Kao YC; Lu CF; Huang HS; Chen CY
    Nanomedicine; 2018 Apr; 14(3):1019-1031. PubMed ID: 29391212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multifunctional polymeric nanoparticles doubly loaded with SPION and ceftiofur retain their physical and biological properties.
    Solar P; González G; Vilos C; Herrera N; Juica N; Moreno M; Simon F; Velásquez L
    J Nanobiotechnology; 2015 Feb; 13():14. PubMed ID: 25886018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved oral bioavailability and therapeutic efficacy of erlotinib through molecular complexation with phospholipid.
    Dora CP; Kushwah V; Katiyar SS; Kumar P; Pillay V; Suresh S; Jain S
    Int J Pharm; 2017 Dec; 534(1-2):1-13. PubMed ID: 28970115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and in vivo evaluation of anti-nucleolin-targeted magnetic PLGA nanoparticles loaded with doxorubicin as a theranostic agent for enhanced targeted cancer imaging and therapy.
    Mosafer J; Abnous K; Tafaghodi M; Mokhtarzadeh A; Ramezani M
    Eur J Pharm Biopharm; 2017 Apr; 113():60-74. PubMed ID: 28012991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and in vitro/in vivo antitumor efficacy of aptamer-targeted Ecoflex
    Ghassami E; Varshosaz J; Jahanian-Najafabadi A; Minaiyan M; Rajabi P; Hayati E
    Int J Nanomedicine; 2018; 13():493-504. PubMed ID: 29416331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functionalized Magnetic Fe
    Nowak-Jary J; Płóciennik A; Machnicka B
    Int J Mol Sci; 2024 Aug; 25(16):. PubMed ID: 39201784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and in vitro evaluation of core-shell type lipid-polymer hybrid nanoparticles for the delivery of erlotinib in non-small cell lung cancer.
    Mandal B; Mittal NK; Balabathula P; Thoma LA; Wood GC
    Eur J Pharm Sci; 2016 Jan; 81():162-71. PubMed ID: 26517962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific targeting of cancer cells by multifunctional mitoxantrone-conjugated magnetic nanoparticles.
    Heidari Majd M; Asgari D; Barar J; Valizadeh H; Kafil V; Coukos G; Omidi Y
    J Drug Target; 2013 May; 21(4):328-40. PubMed ID: 23293842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rhamnolipid-coated W/O/W double emulsion nanoparticles for efficient delivery of doxorubicin/erlotinib and combination chemotherapy.
    Lee Y; Lee D; Park E; Jang SY; Cheon SY; Han S; Koo H
    J Nanobiotechnology; 2021 Dec; 19(1):411. PubMed ID: 34876140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Idarubicin-loaded folic acid conjugated magnetic nanoparticles as a targetable drug delivery system for breast cancer.
    Gunduz U; Keskin T; Tansık G; Mutlu P; Yalcin S; Unsoy G; Yakar A; Khodadust R; Gunduz G
    Biomed Pharmacother; 2014 Jul; 68(6):729-36. PubMed ID: 25194441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multifunctional SPIO/DOX-loaded wormlike polymer vesicles for cancer therapy and MR imaging.
    Yang X; Grailer JJ; Rowland IJ; Javadi A; Hurley SA; Steeber DA; Gong S
    Biomaterials; 2010 Dec; 31(34):9065-73. PubMed ID: 20828811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.